Studies of the Cellular Mechanisms Underlying the Vasorelaxant Effects of Rutaecarpine, a Bioactive Component Extracted from an Herbal Drug
Authors:
- Andrew Yau-Chik ShumASAndrew Yau-Chik Shum
- Jyh-Fei LiaoJLJyh-Fei Liao
- Chieh-Fu ChenCCChieh-Fu Chen
- 1 April 1997
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 29 (4) , 490-498
Abstract
We conducted studies to investigate the nature and underlying mechanisms of the vascular effects of rutaecarpine (Rut), an alkaloid isolated from the Chinese herbal drug Evodia rutaecarpa. By using largely the effects on phenylephrine (PE)-induced contraction in the isolated rat aorta as the experimental index and by comparison with several known vascular muscle relaxants such as acetylcholine (ACh), histamine, and A23187, Rut relaxed PE-precontracted aorta in concentration-(10−7-10−4 M) and endothelium-dependent manners. Studies with appropriate antagonists indicated that this was coupled to nitric oxide (NO) and guanylyl cyclase. Extracellular Ca2+ removal and treatment with the intracellular Ca2+ antagonist, 8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate (TMB-8), suggested that influx of extracellular Ca2+ was the major factor contributing to the action of Rut. Pertussis toxin suppressed the relaxation potency of histamine but had no effects on the actions of Rut. NaF, the G proteins activator, attenuated the actions of ACh, but only minimally affected Na-NP, A23187, and Rut. 1-[6-{[17β-3-methoxyestra-1,2,3(10)-trien-17-yl]amino} hexyl]-1H-pyrrole-2,5-dione (U73122), the phospholipase C inhibitor, again suppressed the actions of ACh but had few effects on A23187 and Rut. Taken together, these results suggest that these vasorelaxants had different cellular mechanisms and that neither pertussis toxin-sensitive Gi protein, other G proteins, nor phospholipase C activation was involved in the cellular response to rutaecarpine.Keywords
This publication has 32 references indexed in Scilit:
- The mechanism of the vasodilator effect of rutaecarpine, an alkaloid isolated from Evodia rutaecarpaEuropean Journal of Pharmacology, 1994
- U-73122, an aminosteroid phospholipase C antagonist, noncompetitively inhibits thyrotropin-releasing hormone effects in GH3 rat pituitary cellsEndocrinology, 1992
- Nucleotide binding proteins in signal transduction and diseaseTrends in Neurosciences, 1987
- Pharmacological Rationale for Antihypertensive Drug TreatmentJournal of Cardiovascular Pharmacology, 1987
- Receptor coupling to polyphosphoinositide turnover: a parallel with the adenylate cyclase systemTrends in Pharmacological Sciences, 1986
- Receptor-regulated G proteinsTrends in Neurosciences, 1986
- Receptor-stimulated phosphoinositide metabolism: a role for GTP-binding proteins?Trends in Biochemical Sciences, 1985
- Role of guanine nucleotide binding protein in the activation of polyphosphoinositide phosphodiesteraseNature, 1985
- Guanine nucleotide-binding regulatory proteins and dual control of adenylate cyclase.Journal of Clinical Investigation, 1984
- Vascular Smooth Muscle: Dual Effect of CalciumScience, 1963